Mark Chen

Mark Chen

Directeur/Membre du Conseil chez GLOBAL CORD BLOOD CORPORATION
58 ans
Finance
Consumer Services
Health Services

Profil

Mr. Mark D.
Chen is an Independent Non-Executive Director at MEGAIN Holding (Cayman) Co. Ltd., an Independent Non-Executive Director at Global Cord Blood Corp.
and a Managing Partner at Pantheon Pacific Capital Management Ltd. He is on the Board of Directors at MEGAIN Holding (Cayman) Co. Ltd. and Global Cord Blood Corp.
Mr. Chen was previously employed as an Independent Director by Skystar Bio-Pharmaceutical Co., a Chairman, President & Chief Executive Officer by Pantheon China Acquisition Corp., a Managing Director by Ecc Advisors LLC, a Managing Director by Easton Capital Investment Group, and a Senior Executive Officer by Suredata, Inc. He also served on the board at Sonics, Inc. He received his undergraduate degree from Shanghai Jiao Tong University, a graduate degree from The Pennsylvania State University and an MBA from Columbia Business School.

Postes actifs de Mark Chen

SociétésPosteDébut
GLOBAL CORD BLOOD CORPORATION Directeur/Membre du Conseil 01/01/2009
MEGAIN HOLDING (CAYMAN) CO., LTD. Directeur/Membre du Conseil 01/02/2021
Corporate Officer/Principal 01/01/2009

Anciens postes connus de Mark Chen

SociétésPosteFin
Directeur Général 05/08/2009
Private Equity Investor 12/03/2006
Directeur Général 01/01/2006
Suredata, Inc.
Fondateur -
SKYSTAR BIO-PHARMACEUTICAL COMPANY Directeur/Membre du Conseil -
Voir l'expérience en détail de Mark Chen

Formation de Mark Chen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

81

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Finance

Health Services

Consumer Services

Technology Services

Finance

Health Technology

Consumer Services

Suredata, Inc.

Consumer Services

Finance

Finance

Electronic Technology